PRAX

Praxis Precision Medicines, Inc.

NasdaqGSUSDEQUITY DELAYED

375.94

▲ 11.36 (3.12%)

MARKET · —

Price

Open

362.19

Prev close

364.58

Day high

387.99

Day low

365.37

Volume

408.26K

Market cap

—

P/E (TTM)

—

52W range

37.19 – 392.70

Trailing performance

Price return · vs SPY

Returnvs SPY

+2.49% +3.9%

+16.61% +12.9%

+7.24% +4.1%

+12.13% +1.1%

YTD

+27.55% +15.3%

+730.81% +710.8%

+2,117.94% +2,043.8%

— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Fundamentals

TTM · reported

Market cap—

Enterprise value—

Revenue (TTM)—

Gross profit—

EBITDA—

Net income—

EPS (TTM)—

Free cash flow—

Total cash—

Total debt—

Book value / share—

Shares outstanding—

Float—

Short % of float—

Dividend yield—

Beta (5Y)—

Valuation & profitability ratios

Account required

Trailing P/E—

Forward P/E—

PEG ratio—

Price / sales—

Price / book—

EV / revenue—

EV / EBITDA—

Gross margin—

Operating margin—

Profit margin—

Return on equity—

Return on assets—

Debt / equity—

Current ratio—

Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Create free account Sign in

Analyst targets & ownership

Account required

Mean target—

High target—

Low target—

Implied upside—

Analyst count—

Consensus—

Strong buy / Buy— / —

Hold—

Sell / Strong sell— / —

Held by insiders—

Held by institutions—

Institutions holding—

Free account required

Price targets, consensus spread, insider and institutional ownership.

Create free account Sign in

Moving averages & technicals

Computed from 2Y daily closes

SMA 10

373.22

+0.73% from price

SMA 20

345.81

+8.71% from price

SMA 50

323.91

+16.06% from price

SMA 100

322.97

+16.40% from price

SMA 200

298.78

+25.82% from price

EMA 12

364.65

+3.10% from price

EMA 26

348.26

+7.95% from price

EMA 50

334.64

+12.34% from price

RSI (14)

59.5

Neutral

MACD (12,26,9)

16.39

Hist 1.73

ATR (14)

22.39

5.96% of price

Realised vol 30D

66.3%

Annualised

Bollinger upper

411.81

20, 2σ

Bollinger lower

279.80

20, 2σ

50 / 200 cross

Golden

323.91 vs 298.78

Trend bias

Above 200

+25.82%

Risk profile

Daily returns · 1Y window

Beta vs SPY

0.41

Less volatile than market

Correlation to SPY

0.03

Largely independent

Realised vol 30D

66.3%

Annualised

Market vol 1Y

12.9%

SPY, annualised

Max drawdown 1Y

-32.6%

Peak to trough

Max drawdown 5Y

-96.5%

Peak to trough

ATR 14

22.39

5.96% of price

Beta (reported)

—

5Y monthly, from filing

Options chain

Account required

ExpirySpot 375.94

Calls

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Puts

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Create free account Sign in

Headlines

PRAX · links out to the publisher

Praxis Precision Medicines Could Be Approaching 'Perfect Trifecta,' Oppenheimer Says MT Newswires · 5d ago Praxis (PRAX) Q2 2026 Earnings Call Transcript Motley Fool · 9d ago 4 Biotech Stocks With Major Second-Half Pipeline Catalysts This Year Zacks · 11d ago Is Praxis (PRAX) Trading Bigger Losses for Long-Run CNS Ambition With Its Cash War Chest? Simply Wall St. · 14d ago RBC Adjusts PT on Praxis Precision Medicines to $462 From $449, Keeps Outperform Speculative Risk Rating MT Newswires · 15d ago Deutsche Bank Adjusts Praxis Precision Medicines PT to $475 From $374, Maintains Buy Rating MT Newswires · 15d ago Praxis Precision Medicines, Inc. Q2 2026 Earnings Call Summary Moby · 15d ago Praxis Precision Medicines Q2 Earnings Call Highlights MarketBeat · 15d ago

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.